Reference |
---|
Cullot G, Boutin J, Fayet S, Prat F, Rosier J, Cappellen D, et al. Cell cycle arrest and p53 prevent ON-target megabase-scale rearrangements induced by CRISPR-Cas9. Nat Commun. 2023;14:4072 pubmed publisher
|
Xiang W, Yang Y, Weng L, Ye Z, Ding P, Li H, et al. Hyperhomocysteinemia activates NLRP3 inflammasome to cause hepatic steatosis and insulin resistance via MDM2-mediated ubiquitination of HSF1. Int Immunopharmacol. 2023;118:110085 pubmed publisher
|
Li M, Zhong A, Wu Y, Sidharta M, Beaury M, Zhao X, et al. Transient inhibition of p53 enhances prime editing and cytosine base-editing efficiencies in human pluripotent stem cells. Nat Commun. 2022;13:6354 pubmed publisher
|
Niu X, Cui H, Gu X, Wu T, Sun M, Zhou C, et al. Nuclear Receptor PXR Confers Irradiation Resistance by Promoting DNA Damage Response Through Stabilization of ATF3. Front Oncol. 2022;12:837980 pubmed publisher
|
Cheng F, Dou J, Zhang Y, Wang X, Wei H, Zhang Z, et al. Urolithin A Inhibits Epithelial-Mesenchymal Transition in Lung Cancer Cells via P53-Mdm2-Snail Pathway. Onco Targets Ther. 2021;14:3199-3208 pubmed publisher
|
Foster D, Chang H, Haswell J, Gregory R, Slack F. TRIM71 binds to IMP1 and is capable of positive and negative regulation of target RNAs. Cell Cycle. 2020;:1-13 pubmed publisher
|
Park J, Park S, Lee Y, Park H, Oh S. PBK attenuates paclitaxel-induced autophagic cell death by suppressing p53 in H460 non-small-cell lung cancer cells. FEBS Open Bio. 2020;10:937-950 pubmed publisher
|
Niederkorn M, Hueneman K, Choi K, Varney M, Romano L, Pujato M, et al. TIFAB Regulates USP15-Mediated p53 Signaling during Stressed and Malignant Hematopoiesis. Cell Rep. 2020;30:2776-2790.e6 pubmed publisher
|
Yang Hartwich Y, Tedja R, Roberts C, Goodner Bingham J, Cardenas C, Gurea M, et al. p53-Pirh2 Complex Promotes Twist1 Degradation and Inhibits EMT. Mol Cancer Res. 2019;17:153-164 pubmed publisher
|
Mungamuri S, Qiao R, Yao S, Manfredi J, Gu W, Aaronson S. USP7 Enforces Heterochromatinization of p53 Target Promoters by Protecting SUV39H1 from MDM2-Mediated Degradation. Cell Rep. 2016;14:2528-37 pubmed publisher
|
Aiken J, Roudier E, Ciccone J, Drouin G, Stromberg A, Vojnovic J, et al. Phosphorylation of murine double minute-2 on Ser166 is downstream of VEGF-A in exercised skeletal muscle and regulates primary endothelial cell migration and FoxO gene expression. FASEB J. 2016;30:1120-34 pubmed publisher
|
Yang Hartwich Y, Soteras M, Lin Z, Holmberg J, Sumi N, Craveiro V, et al. p53 protein aggregation promotes platinum resistance in ovarian cancer. Oncogene. 2015;34:3605-16 pubmed publisher
|
Bhattacharya S, Ghosh M. HAUSP, a novel deubiquitinase for Rb - MDM2 the critical regulator. FEBS J. 2014;281:3061-78 pubmed publisher
|
Yu Y, Wang J, Khaled W, Burke S, Li P, Chen X, et al. Bcl11a is essential for lymphoid development and negatively regulates p53. J Exp Med. 2012;209:2467-83 pubmed publisher
|
Lai C, Tsai A, Chen M, Chang L, Sun H, Chang Y, et al. Aciculatin induces p53-dependent apoptosis via MDM2 depletion in human cancer cells in vitro and in vivo. PLoS ONE. 2012;7:e42192 pubmed publisher
|
Zhou B, Liao Y, Xia W, Zou Y, Spohn B, Hung M. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat Cell Biol. 2001;3:973-82 pubmed
|